Lemieux Julie, Amireault Carl, Camden Stephanie, Poulin Jacqueline
Université Laval, Quebec City, Canada.
Hematology. 2010 Dec;15(6):373-7. doi: 10.1179/102453310X12719010991623.
The objectives of this study were to measure the recruitment, to study characteristics associated with recruitment, and to explore reasons for non-recruitment in clinical trials for malignant hematological diseases. Trials opened between 2002 and 2008 were selected. If the patient fulfilled the main criteria of the protocol, all eligibility criteria of the protocol were assessed. A total of 1394 patients-protocol were identified in 17 protocols (697 patients, since a patient could have been eligible for more than one protocol) and 195 patients-protocol (186 patients) of these fulfilled the main criteria of the protocol. Among the 195 patients-protocol, 133 (68·2%) fulfilled all the eligibility criteria and 45 (23·1%) were recruited. Patients, physicians, and protocol characteristics were not associated with recruitment. The most common reasons for not being recruited were as follow: 40·7%, not fulfilling all eligibility criteria; 31·3%, protocol not being proposed according to the chart; and 22·7%, patients' refusal.
本研究的目的是衡量招募情况,研究与招募相关的特征,并探究恶性血液病临床试验中未被招募的原因。选取了2002年至2008年期间开展的试验。若患者符合方案的主要标准,则评估方案的所有入选标准。在17项方案中总共确定了1394例患者-方案(697例患者,因为一名患者可能符合不止一项方案的入选标准),其中195例患者-方案(186例患者)符合方案的主要标准。在这195例患者-方案中,133例(68.2%)符合所有入选标准,45例(23.1%)被招募。患者、医生和方案特征与招募情况无关。未被招募的最常见原因如下:40.7%,未符合所有入选标准;31.3%,方案未按图表推荐;22.7%,患者拒绝。